These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16237615)

  • 1. Distribution of caffeine levels in urine in different sports in relation to doping control.
    Van Thuyne W; Roels K; Delbeke FT
    Int J Sports Med; 2005 Nov; 26(9):714-8. PubMed ID: 16237615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of caffeine levels in urine in different sports in relation to doping control before and after the removal of caffeine from the WADA doping list.
    Van Thuyne W; Delbeke FT
    Int J Sports Med; 2006 Sep; 27(9):745-50. PubMed ID: 16586337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of caffeine use in elite athletes following its removal from the World Anti-Doping Agency list of banned substances.
    Del Coso J; Muñoz G; Muñoz-Guerra J
    Appl Physiol Nutr Metab; 2011 Aug; 36(4):555-61. PubMed ID: 21854160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of caffeine levels in urine in different sports in relation to doping control before and after the removal of caffeine from the WADA doping list.
    Kuipers H
    Int J Sports Med; 2007 Feb; 28(2):178; author reply 178. PubMed ID: 17290310
    [No Abstract]   [Full Text] [Related]  

  • 5. Caffeine consumption amongst British athletes following changes to the 2004 WADA prohibited list.
    Chester N; Wojek N
    Int J Sports Med; 2008 Jun; 29(6):524-8. PubMed ID: 18027309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeine: use and abuse in sports.
    Delbeke FT; Debackere M
    Int J Sports Med; 1984 Aug; 5(4):179-82. PubMed ID: 6480201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability studies of selected doping agents in urine: caffeine.
    Ventura R; Jiménez C; Closas N; Segura J; De la Torre R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Oct; 795(2):167-77. PubMed ID: 14522021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine Caffeine Concentration in Doping Control Samples from 2004 to 2015.
    Aguilar-Navarro M; Muñoz G; Salinero JJ; Muñoz-Guerra J; Fernández-Álvarez M; Plata MDM; Del Coso J
    Nutrients; 2019 Jan; 11(2):. PubMed ID: 30699902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Declared use of medication in sports.
    Thuyne WV; Delbeke FT
    Clin J Sport Med; 2008 Mar; 18(2):143-7. PubMed ID: 18332689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of doping in Flanders in comparison to the prevalence of doping in international sports.
    Van Eenoo P; Delbeke FT
    Int J Sports Med; 2003 Nov; 24(8):565-70. PubMed ID: 14598191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualitative detection of diuretics and acidic metabolites of other doping agents in human urine by high-performance liquid chromatography-tandem mass spectrometry: comparison between liquid-liquid extraction and direct injection.
    Deventer K; Pozo OJ; Van Eenoo P; Delbeke FT
    J Chromatogr A; 2009 Jul; 1216(31):5819-27. PubMed ID: 19560151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct injection liquid chromatography/electrospray ionization mass spectrometric horse urine analysis for the quantification and confirmation of threshold substances for doping control. II. Determination of theobromine.
    Vonaparti A; Lyris E; Panderi I; Koupparis M; Georgakopoulos C
    Rapid Commun Mass Spectrom; 2009 Apr; 23(7):1020-8. PubMed ID: 19263423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytic evaluation of the beta-human chorionic gonadotropin assay on the Abbott IMx and Elecsys2010 for its use in doping control.
    Shahzad K; Kim DH; Kang MJ
    Clin Biochem; 2007 Nov; 40(16-17):1259-65. PubMed ID: 17884034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A general screening method for doping agents in human urine by solid phase extraction and liquid chromatography/time-of-flight mass spectrometry.
    Kolmonen M; Leinonen A; Pelander A; Ojanperä I
    Anal Chim Acta; 2007 Feb; 585(1):94-102. PubMed ID: 17386652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reference materials for analytical toxicology including doping control: freeze-dried urine samples.
    Jiménez C; Ventura R; Williams J; Segura J; de la Torre R
    Analyst; 2004 May; 129(5):449-55. PubMed ID: 15116239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of caffeine in urine and saliva of horses subjected to urinary acidification.
    Carregaro AB; Mataqueiro MI; Soares OA; Queiroz-Neto A
    J Appl Toxicol; 2004; 24(6):513-8. PubMed ID: 15551384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid-liquid-liquid microextraction followed by HPLC with UV detection for quantitation of ephedrine in urine.
    Bagheri H; Khalilian F; Ahangar LE
    J Sep Sci; 2008 Oct; 31(18):3212-7. PubMed ID: 18773417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoassays for the measurement of IGF-II, IGFBP-2 and -3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport. Values in selected population of athletes.
    Abellan R; Ventura R; Palmi I; di Carlo S; Bacosi A; Bellver M; Olive R; Pascual JA; Pacifici R; Segura J; Zuccaro P; Pichini S
    J Pharm Biomed Anal; 2008 Nov; 48(3):844-52. PubMed ID: 18617352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeine and sport: role of physical exercise upon elimination.
    Duthel JM; Vallon JJ; Martin G; Ferret JM; Mathieu R; Videman R
    Med Sci Sports Exerc; 1991 Aug; 23(8):980-5. PubMed ID: 1956275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doping in cyclism: results of unannounced controls in Flanders (1987-1994).
    Delbeke FT
    Int J Sports Med; 1996 Aug; 17(6):434-8. PubMed ID: 8884418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.